Ecuador -
español -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
gliptina® 50
pharmabrand s.a. ecuador - vildagliptina 50,00 mg / tableta - tabletas - cada tableta contiene: vildagliptina(*) (**) 50,00 mg * se ajustará la cantidad del principio activo de acuerdo a la potencia. ** se incorporará un exceso del 5 % por estabilidad.
Ecuador -
español -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
v-glipt 50
caritas healthcare private limited india - cada tableta no recubierta contiene: vildagliptina???????50 mg - tableta sin recubrimiento - cada tableta no recubierta contiene: vildagliptina???????50 mg
Unión Europea -
español -
EMA (European Medicines Agency)
galvus
novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
Unión Europea -
español -
EMA (European Medicines Agency)
jalra
novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).
Unión Europea -
español -
EMA (European Medicines Agency)
xiliarx
novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).
Perú -
español -
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)
equasis 50mg tableta
farmindustria s.a. - droguerÍa - tableta - por tableta - - vildagliptina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
vildagliptina sandoz 50 mg comprimidos efg
sandoz farmaceutica s.a. - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
vildagliptina krka 50 mg comprimidos efg
krka d.d. novo mesto - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
glypvilo 50 mg comprimidos efg
krka d.d. novo mesto - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina
España -
español -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
vildagliptina teva 50 mg comprimidos efg
teva b.v. - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina